CVE-2022-29939 — MEDIUM (5.4)

Vulnerability Description

In LibreHealth EHR 2.0.0, lack of sanitization of the GET parameters debug and InsId in interface\billing\sl_eob_process.php leads to multiple cross-site scripting (XSS) vulnerabilities.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Librehealth	Librehealth Ehr	2.0.0

Related Weaknesses (CWE)

CWE-79

References

https://github.com/LibreHealthIO/lh-ehr/tagsThird Party Advisory
https://gitlab.com/librehealth/ehr/lh-ehr/-/tagsThird Party Advisory
https://nitroteam.kz/index.php?action=researches&slug=librehealth_rExploitThird Party Advisory
https://github.com/LibreHealthIO/lh-ehr/tagsThird Party Advisory
https://gitlab.com/librehealth/ehr/lh-ehr/-/tagsThird Party Advisory
https://nitroteam.kz/index.php?action=researches&slug=librehealth_rExploitThird Party Advisory

FAQ

What is CVE-2022-29939?

CVE-2022-29939 is a vulnerability with a CVSS score of 5.4 (MEDIUM). In LibreHealth EHR 2.0.0, lack of sanitization of the GET parameters debug and InsId in interface\billing\sl_eob_process.php leads to multiple cross-site scripting (XSS) vulnerabilities.

How severe is CVE-2022-29939?

CVE-2022-29939 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-29939?

Check the references section above for vendor advisories and patch information. Affected products include: Librehealth Librehealth Ehr.